Alterations of basement membrane zone and cutaneous microvasculature in morphea and extragenital lichen sclerosus

American Journal of Dermatopathology

Volumn 27, Issue 6, 2005, Pages 489-496

  Kowalewski, Cezary ^a   Kozłowska, Anna ^a   Górska, Marta ^a   Woźniak, Katarzyna ^a   Krajewski, MacIej ^a   Błaszczyk, Maria ^a   Jabłońska, Stefania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Angiogenesis; Basement membrane zone; Laser scanning confocal microscopy; Lichen sclerosus; Morphea

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LAMINA PROPRIA; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MICROVASCULATURE; MORPHEA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN BLOOD FLOW; THREE DIMENSIONAL IMAGING; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; LOCALIZED SCLERODERMA; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SKIN; ULTRASTRUCTURE; VASCULARIZATION;

ADULT; AGED; BASEMENT MEMBRANE; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LICHEN SCLEROSUS ET ATROPHICUS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SCLERODERMA, LOCALIZED; SKIN;

EID: 33644815817     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000183679.40184.23     Document Type: Article

References (50)

1. Jabłońska S. Scleroderma and Pseudoscleroderma. Polish Med Publ Warsaw, English edition. Stroudsburg, PA: Dowden Hutchinson Inc.; 1975.
2. Marzano AV, Menni S, Parodi A, et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol. 2003;13:171-176.
3. Krafchik BR. Localized morphea in children. Adv Exp Med Biol. 1999;45:549-554.
4. Sidky YA, Auerbach R. Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction. J Exp Med. 1975;141:1084-1100.
5. Fleischmajer R, Perish JS, Shaw KV, et al. Skin capillary changes in early systemic scleroderma. Arch Dermatol. 1976;111:1553-1557.
6. Higley H, Persichitte K, Chu S, et al. Immunocytochemical localization and serologic detection of transforming growth factor β1. Arthritis Rheum. 1994;37:278-288.
7. Brinckmann J, Neess CM, Gaber Y, et al. Different pattern of collagen cross-links in two sclerotic skin diseases: lipodermatosclerosis and circumscribed scleroderma. J Invest Dermatol. 2001;117:269-273.
8. Brown M, Vaughan J, Jimenez L, et al. Transforming growth factor-β: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology. 1991;129:2355-2360.
9. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by "wilde-field" microscopy. Arthritis Rheum. 1973;16:619-628.
10. Hembold P, Fiedler E, Fisher M, et al. Hyperplasia of dermal microvascular pericytes in scleroderma. J Cutan Pathol. 2004;31:431-440.
11. Fleischmajer R, Perish J. Capillary alterations in scleroderma. J Am Acad Dermatol. 1980;2:161-170.
12. Patterson KA, Ackerman AB. Lichen sclerosus et atrophicus is not related to morphea. Am J Dermatopathol. 1984;6:323-335.
13. Rahbari H. Histochemical differentiation of localized morphea-scleroderma and lichen sclerosus et atrophicus. J Cutan Pathol. 1989;16:342-347.
14. Nishioka S. Histological comparison of morphea and lichen sclerosus et atrophicus. Kurume Med J. 1997;44:83-90.
15. Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus. The course after puberty. J Reprod Med. 2002;47:706-709.
16. Wakelin SH, Marren P. Lichen sclerosus in women. Clin Dermatol. 1997;15:155-169.
17. Derrick EK, Ridley CM, Kobza-Black A, et al. A clinical study of 23 cases of female anogenital carcinoma. Br J Dermatol. 2000;143:1217-1223.
18. Wu KH, Dai YS, Tsai MJ, et al. Lichen sclerosus et atrophicus, bullous morphea, and systemic lupus erythematosus: a case report. J Microbiol Immunol Infect. 2000;33:53-56.
19. Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet. 2003;362:118-123.
20. Han Z, Ni J, Smits P, et al. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J. 2001;15:988-994.
21. Regauer S, Liegl B, Reich O, et al. Vasculitis in lichen sclerosus: an under recognized feature? Histopathology. 2004;45:237-244.
22. Fung MA, LeBoit PE. Light microscopic criteria for the diagnosis of early lichen sclerosus. Am J Surg Pathol. 1998;22:473-478.
23. LeBoit PE. A thickened basement membrane is a clue to lichen sclerosus. Am J Dermatopathol. 2000;22:457-458.
24. Mann PR, Cowan MA. Ultrastructural changes in four cases of lichen sclerosus et atrophicus. Br J Dermatol. 1973;89:223-231.
25. Mihara Y, Mihara M, Hagari Y, et al. Lichen sclerosus et atrophicus. A histological, immunochemical and electron microscopic study. Arch Dermatol Res. 1994;286:434-444.
26. Marren P, Dean D, Chamock M, et al. The basement membrane zone in lichen sclerosus. An immunohistochemical study. Br J Dermatol. 1997;136:508-514.
27. Kowalewski C, Kozlowska A, Wozniak K, et al. Alterations of basement membrane zone in bullous and non bullous variant of extragenital lichen sclerosus. Am J Dermatopathol. 2004;26:96-101.
28. Sawamura D, Yaguchi T, Hashimoto I, et al. Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus and lichen planus. J Dermatol. 1998;25:409-411.
29. Connelly MG, Winkelmann RK. Coexistance of lichen sclerosus, morphea and lichen planus. J Am Acad Dermatol. 1985;12:844-851.
30. McNiff JM, Glusac EJ, Lazova RZ, et al. Morphea limited to the superficial reticular dermis: an underrecognized histologic phenomenon. Am J Dermatopathol. 1999;21:315-319.
31. De Vito JR, Merogi AJ, Vo T, et al. Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases. J Cutan Pathol. 1996;23:350-358.
32. Fujiwara H, Fujiwara K, Hashimoto K, et al. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol. 1997;133:41-44.
33. Ozkan S, Atabey N, Fetil E, et al. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol. 2000;39:278-283.
34. Weide B, Walz T, Garbe C. Is morphea caused by Borrelia burgdorferi? A review. Br J Dermatol. 2000;142:636-644.
35. Cordoba S, Vargas E, Frage J, et al. Lichen sclerosus in sclerodermatous chronic graft versus host disease. Int J Dermatol. 1999;38:709-711.
36. Tabata H, Yamakage A, Yamazaki S. Electron-microscopic study of sclerodermatous chronic graft versus host disease. Int J Dermatol. 1996;35:862-866.
37. Aractingi S, Chosidow O. Cutaneous graft-versus-host-disease. Arch Dermatol. 1998;134:602-612.
38. Doyle JA, Connolly SM, Winkelmann RK. Cutaneous and subcutaneous inflammatory sclerosis syndromes. Arch Dermatol. 1982;118:886-890.
39. Braverman IM. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic stages. J Invest Dermatol. 1989;93:2S-9S.
40. Braverman IM. The cutaneous microcirculation. J Invest Dermatol Symp Proc. 2000;5:3-9.
41. Kowalewski C, Kozlowska A, Chan I, et al. Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus. J Dermatol Sci. 2005;38:215-224.
42. Chan I. The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol. 2004;29:52-56.
43. Mongiat M, Fu J, Oldershaw R, et al. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. Biol Chem. 2003;278:17491-17499.
44. Fujimoto N, Terlizzi J, Brittingham R, et al. Extracellular matrix protein 1 interacts with the domain III of fibulin-1C and 1D variants through its central tandem repeat 2. Biochem Biophys Res Commun. 2005;333:1327-1333.
45. Korn JH. Interaction of immune and connective tissue cells. Int J Dermatol. 1980;19:487-495.
46. Dvorak HF, Brown LH, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability and angiogenesis. Am J Pathol. 1995;146:1029-1039.
47. Detmar M, Brown LH, Claffey KP, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994;180:1141-1146.
48. Jaffe BD, Claman HN. Chronic graft-versus-host disease (GVHD) as a model for scleroderma. I. Description of model systems. Cell Immunol. 1983;77:1-12.
49. Kahaleh MB, LeRoy EC. Endothelial injury in scleroderma. J Lab Clin Med. 1983;101:553-560.
50. Martini G, Murray KJ, Howell KJ, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford). 2002;41:1178-1182.